We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+14.87%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$6.83B
AUM Growth
+$1.02B
Cap. Flow
+$234M
Cap. Flow %
3.43%
Top 10 Hldgs %
21.97%
Holding
591
New
39
Increased
207
Reduced
104
Closed
35

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$36.7M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$11.3M
3
LGIH icon
LGI Homes
LGIH
+$10.4M
4
CMI icon
Cummins
CMI
+$9.78M
5
MRK icon
Merck
MRK
+$9.77M

Sector Composition

Rank Sector Weight
1 Technology 34.29%
2 Healthcare 17.66%
3 Consumer Discretionary 9.75%
4 Industrials 9.46%
5 Financials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KROS icon
476
Keros Therapeutics
KROS
$222M
$234K ﹤0.01%
5,700
FAF icon
477
First American
FAF
$7.58B
$208K ﹤0.01%
3,200
SIG icon
478
Signet Jewelers
SIG
$3.78B
$193K ﹤0.01%
1,793
MRVI icon
479
Maravai LifeSciences
MRVI
$916M
$191K ﹤0.01%
28,400
ADPT icon
480
Adaptive Biotechnologies
ADPT
$3.95B
$190K ﹤0.01%
35,700
SIGI icon
481
Selective Insurance
SIGI
$5.72B
$179K ﹤0.01%
1,800
SANA icon
482
Sana Biotechnology
SANA
$980M
$174K ﹤0.01%
40,000
AVXL icon
483
Anavex Life Sciences
AVXL
$310M
$173K ﹤0.01%
18,000
VERV
484
DELISTED
Verve Therapeutics
VERV
$169K ﹤0.01%
11,300
VLTO icon
485
Veralto
VLTO
$24B
$165K ﹤0.01%
+1,981
New +$148K
BRK.B icon
486
Berkshire Hathaway Class B
BRK.B
$1.12T
$159K ﹤0.01%
445
-50
-10% -$17.6K
KURA icon
487
Kura Oncology
KURA
$847M
$157K ﹤0.01%
11,000
EDIT icon
488
Editas Medicine
EDIT
$442M
$155K ﹤0.01%
15,000
SU icon
489
Suncor Energy
SU
$70.2B
$154K ﹤0.01%
4,800
ZNTL icon
490
Zentalis Pharmaceuticals
ZNTL
$299M
$153K ﹤0.01%
9,800
ALEC icon
491
Alector
ALEC
$199M
$152K ﹤0.01%
19,000
TDOC icon
492
Teladoc Health
TDOC
$1.3B
$147K ﹤0.01%
6,649
AEM icon
493
Agnico Eagle Mines
AEM
$90.7B
$138K ﹤0.01%
2,500
ABEV icon
494
Ambev
ABEV
$46.4B
$124K ﹤0.01%
44,000
+22,000
+100% +$59.4K
PHM icon
495
Pultegroup
PHM
$25.3B
$117K ﹤0.01%
1,130
+660
+140% +$56.1K
LYEL icon
496
Lyell Immunopharma
LYEL
$352M
$114K ﹤0.01%
2,700
FNF icon
497
Fidelity National Financial
FNF
$13.5B
$113K ﹤0.01%
2,200
BTG icon
498
B2Gold
BTG
$6.72B
$104K ﹤0.01%
32,500
-678,958
-95% -$2.14M
ALLO icon
499
Allogene Therapeutics
ALLO
$694M
$103K ﹤0.01%
31,400
REPL icon
500
Replimune Group
REPL
$1B
$102K ﹤0.01%
11,900

Similar funds

Erste Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Erste Asset Management held 591 positions worth $6.83B, up 18% from $5.81B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $234M of net new capital in Q4 2023, opening 39 new positions and adding to 207 existing holdings. Its largest new stake was AutoZone: 3,190 shares worth $8.25M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was LGI Homes, an estimated $10.4M trimmed.

  • Erste Asset Management's largest Q4 2023 buy was AutoZone: 3,190 shares worth $8.25M.
  • Erste Asset Management added most to Intel in Q4 2023, an estimated $16M increase.
  • Erste Asset Management's biggest Q4 2023 reduction was LGI Homes, cutting an estimated $10.4M.
  • Erste Asset Management fully exited Hess in Q4 2023, selling an estimated $36.7M.
  • Erste Asset Management's ten largest holdings make up 22% of its $6.83B portfolio in Q4 2023.
  • Erste Asset Management opened 39 new positions and closed 35 in Q4 2023.
  • Erste Asset Management's portfolio value rose 18% quarter-over-quarter to $6.83B.

Based on Erste Asset Management's 13F filing for Q4 2023, filed 26 Nov 2024.